...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ZHCLF

Yes , earlier this morning. Now would you be more inclined to think somethings coming sooner or later based on this?

DATE
TIMESTAMP
PRICE
VOLUME
01/03/2024 10:58:27
0.10
321,300
Share
New Message
Please login to post a reply